K

Kernal Biologics

31 employees

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
synthetic biology
RNA design
Therapeutics
immunotherapy
covid-19
cancer
Pharmaceutical
mRNA therapy

Date founded

2016

Funding rounds raised

Total raised

$25M

from 7 investors over 7 rounds

K

Kernal Biologics raised $25M on July 7, 2022

Investors: Amino Collective, HBM Genomics, Hummingbird Ventures and Civilization Ventures

K

Kernal Biologics raised undisclosed on October 21, 2020

Investors: Y Combinator and SAV (Scale Asia Ventures)

K

Kernal Biologics raised undisclosed on October 18, 2018

Investors: International Space Station U.S. National Laboratory

FAQ